GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (FRA:PI3) » Definitions » DeferredTaxAndRevenue

Gubra AS (FRA:PI3) DeferredTaxAndRevenue : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Gubra AS's current deferred tax and revenue for the quarter that ended in Jun. 2024 was €0.00 Mil.

Gubra AS DeferredTaxAndRevenue Historical Data

The historical data trend for Gubra AS's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS DeferredTaxAndRevenue Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - - - -

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

Gubra AS DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Gubra AS's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment.

Gubra AS Headlines

No Headlines